PP2A binds to the LIM domains of Lipoma-Preferred Partner through its PR130/B" subunit to regulate cell adhesion and migration by Janssens, Veerle et al.
RESEARCH ARTICLE
PP2A binds to the LIM domains of lipoma-preferred partner
through its PR130/B″ subunit to regulate cell adhesion and
migration
Veerle Janssens1,2,*, Karen Zwaenepoel2, Carine Rossé1,3, Marleen M. R. Petit4, Jozef Goris2 and
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ABSTRACT
Here, we identify the LIM protein lipoma-preferred partner (LPP) as a
binding partner of a specific protein phosphatase 2A (PP2A)
heterotrimer that is characterised by the regulatory PR130/B″α1
subunit (encoded by PPP2R3A). The PR130 subunit interacts with
the LIM domains of LPP through a conserved Zn2+-finger-like motif in
the differentially spliced N-terminus of PR130. Isolated LPP-
associated PP2A complexes are catalytically active. PR130
colocalises with LPP at multiple locations within cells, including
focal contacts, but is specifically excluded from mature focal
adhesions, where LPP is still present. An LPP–PR130 fusion
protein only localises to focal adhesions upon deletion of the
domain of PR130 that binds to the PP2A catalytic subunit (PP2A/
C), suggesting that PR130–LPP complex formation is dynamic and
that permanent recruitment of PP2A activity might be unfavourable for
focal adhesion maturation. Accordingly, siRNA-mediated knockdown
of PR130 increases adhesion of HT1080 fibrosarcoma cells onto
collagen I and decreases their migration in scratch wound and
Transwell assays. Complex formation with LPP is mandatory for
these PR130-PP2A functions, as neither phenotype can be rescued
by re-expression of a PR130 mutant that no longer binds to LPP. Our
data highlight the importance of specific, locally recruited PP2A
complexes in cell adhesion and migration dynamics.
KEY WORDS: Cell migration, Cell adhesion, LIM domain, Lipoma-
preferred partner, Protein phosphatase 2A, Zn2+-finger
INTRODUCTION
Cell migration is a dynamic process requiring integration and
coordination of many cellular events, including the establishment of
cell polarity, the regulation of dynamic actin and microtubule
polymerisation, and the dynamic regulation of cell–cell and cell–
substratum interactions (Ridley et al., 2003; Ridley, 2011). In all of
these spatially and temporally controlled signalling processes,
protein phosphorylation – on tyrosine as well as on serine or
threonine (Ser/Thr) residues – plays a vital regulatory role. Although
the involvement and manipulation of specific, locally recruited Ser/
Thr protein kinases has been well documented (Huang et al., 2004;
Boeckeler et al., 2010; Rossé et al., 2010; Howe, 2011; McDonald,
2014), it is much less understood whether the localised action of
counteracting Ser/Thr phosphatases is important in these events.
Protein phosphatase 2A (PP2A) is a ubiquitously expressed
phosphatase with a complex structure and regulation that is
increasingly coming into focus as a tumour suppressor (Janssens
et al., 2005; Westermarck and Hahn, 2008) and novel anti-cancer
target (Perrotti and Neviani, 2013). Currently, relatively little is
known about the role of specific PP2A complexes in control of
cytoskeletal dynamics, (cancer) cell adhesion, migration or invasion
(Sontag and Sontag, 2006; Basu, 2011). Through the use of okadaic
acid, a phosphatase inhibitor affecting all PP2A holoenzymes
(Lambrecht et al., 2013), it has been shown that PP2A can restrict
migration of various cell types, in line with its tumour suppressor
function (Maier et al., 1995; Young et al., 2002; Pullar et al., 2003).
By contrast, other studies have reported impaired cell motility upon
pharmacologic inhibition of PP2A, rather suggesting a pro-
migratory role for PP2A (Basu et al., 2007; Wu et al., 2014).
Although these inhibitor studies are informative, it is difficult to
draw specific conclusions about the in vivo roles of PP2A because
the global suppression of phosphatase activity affects many cellular
processes, and can result in indirect and even opposing effects.
Dissecting the in vivo roles of PP2A requires detailed molecular
analyses of the contexts into which the phosphatase is drawn
through the particular targeting and regulatory devices that
comprise the plethora of PP2A complexes.
PP2A enzymes typically exist as trimers comprising a catalytic C
subunit, a structural A subunit and a variable regulatory B-type
subunit (Fig. 1A). Regulation occurs through the interaction of the
catalytic subunit – through the A subunit – with these regulatory
subunits, which act as targeting and/or substrate-specifying entities
(Janssens and Goris, 2001; Lambrecht et al., 2013). PR72 (B″α2)
and PR130 (B″α1) belong to the B″-family of PP2A regulatory
subunits (Fig. 1A), whose physiological roles are still poorly
understood. These particular B″ subunits are derived from the same
gene (PPP2R3A) through differential splicing (Fig. 1A); they
harbour specific N-terminal domains of 45 and 664 amino acids
that are encoded by alternatively spliced exons, and have identical
C-termini of 486 amino acids (Hendrix et al., 1993; Stevens et al.,
2003; Zwaenepoel et al., 2008). The common C-terminus contains
two A-subunit-interaction domains (Li and Virshup, 2002), a
conserved hydrophobic motif (Davis et al., 2008) and two
Ca2+-binding EF-hands, which mediate Ca2+-dependent changes
in phosphatase activity and provide an important interaction
interface with the A subunit (Janssens et al., 2003; Ahn et al.,
2007; Park et al., 2013). Recent structural studies on the related
PR70 (B″β1) subunit (encoded by PPP2R3B) have largelyReceived 13 June 2015; Accepted 18 February 2016
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Fig. 1. PP2APR130/B″α1 forms an endogenous complexwith LPP. (A) Scheme of PP2A holoenzyme structure, and the domain structure of PR130/B″α1 and
PR72/B″α2, two splice variants encoded by PPP2R3A. Together with PR70/B″β1 and PR70/B″β2 (both encoded by PPP2R3B) and G5PR/B″γ (encoded by
PPP2R3C), these subunits constitute the human B″ subunits of PP2A (Zwaenepoel et al., 2008). Interaction with the A (and C) subunit is mediated by the shared
486-amino-acid C-terminal domain that contains a hydrophobic motif (HM) and two Ca2+-binding EF-hands (EF1 and EF2). (B) Validation of the interactions
identified by yeast two-hybrid screening of a human testis library with PR130 (residues 1–664) as bait. The AH109 yeast strain was retransformed with the
indicated plasmids and plated on growthmediumwithout Leu and Trp for selection of double transformants. One colony of each condition was replated onmedium
lacking Leu, Trp, His and adenine to assay for expression of the HIS and ADE reporter genes. (C) Mass spectroscopic fingerprinting from co-immunoprecipitating
proteins in anti-PR130 immunoprecipitates (IPs) from NIH3T3 cell lysates. Immunoprecipitation with the pre-immune serum served as negative control. SDS-
PAGE-separated proteins were stained with Coomassie Brilliant Blue. (D) Co-immunoprecipitation of endogenous PR130, LPP, the PP2A A subunit PR65
(encoded byPPP2R1A) and C subunit fromNIH3T3 cell lysates. PR130was immunoprecipitated with anti-PR130 antibodies, and the presence of LPP, the PP2A
A subunit PR65 and the C subunit in the immunoprecipitates was evaluated by immunoblotting (IB). Ig, immunoglobulins. (E) Co-immunoprecipitation of
endogenous PR130 and LPP from HT1080 cell lysates. PR130 was immunoprecipitated with anti-PR130 antibodies, and the presence of LPP in the
immunoprecipitates was revealed by immunoblotting (IB). Ig, immunoglobulins. (F) Specific interaction between LPP and the PR130/B″α1 (PR130) subunit of
PP2A. GST, GST-tagged PP2A subunit representatives of the PR55/B (α isoform, PR55α), PR61/B′ (ε isoform, PR61ε) and PR72/B″ families (PR70/B″β1
isoform, PR70), GST-tagged PR130/B″α1 (PR130) and the closely related PPP2R3A splice variant PR72/B″α2 (PR72) were ectopically expressed in COS7
cells. Following GST pull down, co-precipitating LPP was visualised by immunoblotting (IB). (G) No interaction of PR130 with zyxin, a LIM-domain protein that is
closely related to LPP. EGFP, EGFP-tagged LPP and EGFP-tagged zyxin were ectopically expressed in COS7 cells and immunoprecipitated with anti-EGFP
antibodies. The presence of co-immunoprecipitating PR130 was visualised by immunoblotting (IB).
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confirmed these biochemical data (Wlodarchak et al., 2013; Dovega
et al., 2014). Functionally, it has been shown that although PR72
and PR130 both interact with the Wnt antagonist Naked cuticle
(Nkd), PR72 represses canonical Wnt signalling through this
interaction (Creyghton et al., 2005), whereas PR130 rather restricts
the ability of Nkd to function as a Wnt inhibitor and thus promotes
canonical Wnt signalling (Creyghton et al., 2006). It has therefore
been suggested that these opposing cellular functions are likely to be
mediated by their specific N-terminal domains (Creyghton et al.,
2006). In contrast, the interaction of PR130 with the inositol
polyphosphate 5-phosphatase SHIP2 occurs through the 486-
amino-acid common domain, and positively contributes to EGF-
mediated signalling by preventing EGF-receptor degradation
(Zwaenepoel et al., 2010). Thus, the few molecular data on
PR130 cellular function, so far, have merely suggested a proto-
oncogenic role for the PR130-PP2A holoenzyme.
By exploiting the specific PR130 N-terminus as bait in a yeast
two-hybrid screen, we now describe a new cellular complex
comprising PR130-PP2A and the focal adhesion protein lipoma-
preferred partner (LPP) that appears to be functionally important in
the control of (cancer) cell adhesion and migration. Our data
highlight the importance of specific, locally recruited trimeric PP2A
complexes in cell adhesion and migration dynamics.
RESULTS
Identification of LPP as a cellular PR130-binding partner
To obtain insight into the poorly established physiological functions
and substrates of the PR130-PP2A holoenzyme, we performed a
yeast two-hybrid screen exploiting the unique PR130-specific N-
terminus (PR130 amino acids 1–664) as bait. We identified five
independent N-terminally-truncated clones of LPP (Petit et al.,
1996) starting at amino acid residues 144, 146, 309, 314 and 344.
We re-tested both the shortest (LPP 344–612) and the longest of
these clones (LPP 144–612), together with full-length LPP (1–612)
and confirmed the interaction with LPP, both for full-length PR130
and its specific N-terminal domain (PR130 1–664) (Fig. 1B).
To validate this observation on endogenous proteins, we used a
PR130-specific antibody (Zwaenepoel et al., 2008) and identified
the co-immunoprecipitating proteins using mass spectroscopy.
Three different LPP peptides (Materials and Methods) were
unambiguously identified from a specific co-precipitating protein
with an apparent molecular mass of 75 kDa (Fig. 1C). To confirm
these data, we counter-stained immunoprecipitates that had been
isolated with an antibody against PR130 from NIH3T3 cells with a
specific LPP antibody, revealing LPP immunoreactivity (Fig. 1D).
Higher stringency washes of these immunoprecipitates (increasing
NaCl concentrations up to 600 mM) could not completely disrupt
the complex, suggesting that binding is strong (results not shown).
The complex could also be identified in HT1080 (Fig. 1E) and COS
cells (results not shown), indicating that complex formation is not
cell type-specific. By contrast, LPP failed to interact with other
PP2A B-type subunits from the same subclass (PR72/B″α2 and
PR70/B″β1) or other subclasses (PR55/Bα and PR61/B′ε, encoded
by PPP2R2A and PPP2R5E, respectively) (Fig. 1F), indicating that
the interaction of LPP with PP2A is specific for PR130. Similarly,
PR130 did not interact with zyxin, a closely related LPP LIM-
protein-family member (Fig. 1G).
PR130 interacts with the LIM domains of LPP through a
cysteine-rich Zn2+-finger-like domain
The LPP-interaction domain within PR130 was mapped to the
N-terminus (1–106) (Fig. 2A). Deletion of the first 34 or 59 amino
acids of PR130 abolished the interaction with LPP, whereas deletion
of the first 9 or 19 amino acids decreased the LPP interaction only in
relation to the decrease in recovery of the truncated PR130 protein
itself (Fig. 2B). An alignment of the PR130 N-terminal region from
different vertebrates revealed a high overall degree of conservation,
especially within the first 55 amino acids, where several conserved
cysteine and histidine residues are present. This cysteine-rich
domain shows homology with a known C1-like Zn2+-finger domain
of the barley stripe mosaic viral γb protein (Bragg et al., 2004)
(Fig. 2C). Alanine substitutions of all cysteine residues within the
C1-like domain (Cys31, Cys35, Cys44 and Cys52) severely
diminished the interaction with LPP (Fig. 2B), consistent with a
functional role of this domain in mediating LPP binding.
As supported by the yeast two-hybrid data, PR130 specifically
interacted with the LPP LIM domains (residues 415–612), but not
with the non-LIM region (residues 1–415) (Fig. 2D). LPP
encompasses three LIM domains (Petit et al., 2003), and deletion
of any LIM domain in the context of the isolated three LIM domains
inhibited binding to PR130, suggesting that all LIM domains
contribute to the interaction (Fig. 2E). We also generated LIM-
domain mutants in the context of full-length LPP by changing four
structurally important cysteine or histidine residues per LIM domain
into alanine residues (Petit et al., 2003). Although the double LIM-
domain mutants and two of the single-domain LIM mutants (LPP-
LIM2mut and LPP-LIM3mut) failed to bind to PR130, the single
LPP LIM1-domain mutant still retained some binding capacity
(Fig. 2F). Thus, in the context of the complete LPP protein, the
integrity of both the LIM2 and LIM3 domains is more important for
the interaction with PR130 than the integrity of the LIM1 domain,
although, in isolation, the LIM2 and LIM3 domains alone are
insufficient for PR130 binding.
LPP binds to a catalytically competent PR130-containing
PP2A trimer
To further characterise the endogenous LPP–PR130 complex, we
performed the reciprocal immunoprecipitation with an antibody
against LPP and revealed that, besides PR130, the PP2A A and C
subunits (the catalytic subunit is referred to as PP2A/C) are also
present in the complex (Fig. 3A). Therefore, a PP2A heterotrimer is
bound to LPP. This LPP-associated PR130-PP2A holoenzyme
proved catalytically competent, as okadaic-acid-sensitive
phosphatase activity was measured in GFP-trapped complexes
retrieved from GFP–LPP-expressing HEK293T cells, but not from
cells expressing GFP alone (Fig. 3B).
In contrast with LPP, PR130 is excluded from mature focal
adhesions
We next determined the localisation of the endogenous LPP–PR130
complex by direct immunofluorescence (Fig. 4). It is well
established that all three LIM domains of LPP cooperate to
provide targeting to cell–cell and cell–matrix contacts, particularly
to focal adhesions where LPP colocalises, for example, with the
focal adhesion marker vinculin (Petit et al., 2003). Shortly after
plating, when stable focal adhesions have not yet completely
formed, PR130 and LPP colocalised at the cell periphery of HT1080
fibrosarcoma cells, presumably at focal contacts (Fig. 4A). In
contrast, PR130 was strikingly absent from mature focal adhesions
of spread HT1080 cells, where LPP (and vinculin) were clearly
present (Fig. 4B,C). Further, there was a good colocalisation of both
proteins at cell–cell contacts (Fig. 4D), in the (perinuclear)
cytoplasm (Fig. 4C,D) and in the nucleus, including the nuclear
membrane or lamina (Fig. 4D). Upon nuclear accumulation of LPP,
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by blocking its nuclear export with leptomycin B (Petit et al., 2000),
this nuclear colocalisation was further intensified (results not
shown). The difference in LPP and PR130 colocalisation between
adhering and spread cells was not due to potential changes in PR130
expression levels in these conditions (Fig. 4E).
To provide further support for our interpretation of the
immunofluorescence data that LPP and PR130 might colocalise at
focal contacts, but no longer do so in more mature focal adhesions,
we stained for phosphorylated (phospho-)tyrosine residues (clone
4G10 antibody), a marker of focal adhesions, and for paxillin (clone
5H11 antibody), a marker of both focal contacts and focal adhesions
(Madsen et al., 2015). Again, in spread cells, there was no
colocalisation of PR130 with either paxillin (Fig. 4F) or phospho-
tyrosine (Fig. 4G) at focal adhesions, whereas in adhering cells,
Fig. 2. PR130 interacts with the LIM domains of LPP through a conserved cysteine-rich Zn2+-finger-like domain. (A) Mapping the LPP-interacting domain
within PR130, throughGST pull down fromCOS7 cells overexpressing GST fusion proteins of different PR130 deletions. The presence of endogenous LPP in the
pull downs was detected with LPP antibodies. Asterisks indicate the bands corresponding to the GST fusion proteins. (B) Sequential deletions and site-directed
mutagenesis of the LPP-binding domain of PR130. C-terminally Myc-tagged PR130, PR130(10–1150), PR130(20–1150), PR130(35–1150), PR130(60–1150)
and a PR130 4CtoA mutant in which Cys31, Cys35, Cys44 and Cys52 had been mutated into alanine residues, were expressed in COS7 cells. The presence of
endogenous LPP in the anti-Myc immunoprecipitates (IP) was evaluated with anti-LPP antibodies. IB, immunoblot. (C) Alignment of the LPP interaction domain of
PR130 proteins from different species, illustrating the evolutionary conservation within the first 60 amino acids, and the similarity with a C1-like domain of the
BSMV γb protein. The conserved cysteine and histidine residues are boxed. (D) Mapping the PR130-binding domain within LPP, through anti-Myc
immunoprecipitation fromCOS7 cells overexpressing C-terminally Myc-tagged LPP, the LPP non-LIM region (residues 1–415) or the LIM domains (residues 415–
612). The presence of endogenous PR130 in the anti-Myc immunoprecipitates (IPs) was detected with anti-PR130 antibodies. LPP counter-staining was
performed with LPP- and Myc-specific antibodies, because the LPP-specific antibody does not recognise the LPP LIM region. (E) Requirement of all three LIM
domains for the interaction with PR130. N-terminally EGFP-tagged LPP(415–612) comprising the LIM1, LIM2 and LIM3 domains (LIM1/2/3); LPP(415–535)
comprising the LIM1 and LIM2 domains (LIM 1/2); LPP(475–612) comprising the LIM2 and LIM3 domains (LIM 2/3), LPP(415–475) comprising the LIM1 domain
(LIM1), LPP(475–535) comprising the LIM2 domain (LIM2); and LPP(535–612) comprising the LIM3 domain (LIM3) were overexpressed in COS7 cells. The
presence of endogenous PR130 in the recovered anti-EGFP immunoprecipitates was detected with PR130-specific antibodies. (F) Differential effects of mutation
of a single LPP LIM domain on the interaction with PR130. The structure of any single LPP LIM domain was disrupted by mutating four Zn2+-binding cysteine and
histidine residues into alanine residues (Petit et al., 2003). N-terminally EGFP-tagged LPP, LPP-LIM1mut, LPP-LIM2mut, LPP-LIM3mut, LPP-LIM1/2mut, LPP-
LIM1/3mut and LPP-LIM2/3mut were overexpressed in COS7cells, and the presence of endogenous PR130 was detected in the recovered EGFP
immunoprecipitates using PR130-specific antibodies.
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the peripherally accumulated ‘PR130 patches’ did colocalise
substantially with paxillin (Fig. 4F), but much less with phospho-
tyrosine (Fig. 4G). Thus, the endogenous PR130–LPP complex can
be visualised at multiple locations within cells, including the focal
contacts, but is strikingly absent from mature focal adhesions.
Exclusion of PR130 from focal adhesions is a function of
PP2A activity
The absence of PR130 frommature focal adhesions suggests that the
PR130–LPP complex is not constitutive andmight dissociate during
focal adhesion maturation. It has been reported that β-galactosidase
can be targeted to focal adhesions by covalent binding to GFP–LPP
or GFP-tagged LIM domains of LPP (Petit et al., 2003). To further
explore why PR130 is excluded from focal adhesions, we generated
a GFP–PR130(60–1150)–LPP fusion protein, in an attempt to force
the complex into focal adhesions. We deliberately excluded the
LPP–binding domain of PR130 (residues 1–59) from this fusion
protein to eliminate the potential influence of endogenous LPP
binding during the subcellular targeting of the fusion protein. In
contrast to GFP–LPP, expression of the truncated fusion protein did
not lead to an accumulation in the focal adhesions (Fig. 5A),
suggesting that the forced presence of PR130(60–1150) in the LPP
complex somehow inhibits the focal-adhesion-targeting capacity of
LPP. However, deletion of the PP2A/C-binding domain of PR130
(amino acids 665–1150) did lead to an accumulation of the resulting
GFP–PR130(60–664)–LPP fusion protein in 4G10-positive focal
adhesions (Fig. 5A), demonstrating a requirement for phosphatase
association with PR130 to block focal adhesion accumulation. GFP-
trapping of the fusion proteins confirmed their binding behaviour
towards PP2A/C (Fig. 5B). Thus, an active dissociation mechanism
might operate for the LPP–PR130-PP2A complex in order to permit
entry into or maturation of focal adhesions.
PR130 inhibits HT1080 cell adhesion onto collagen I in an
LPP-dependent way
The former observations (Fig. 5) suggest that LPP-dependent
recruitment of PR130-associated PP2A activity (Fig. 3) is
unfavourable for focal adhesion maturation and predict that
PR130 exerts a negative effect on cell–matrix adhesion. To test
this hypothesis, PR130 expression was suppressed by performing
RNA interference (RNAi) in HT1080 cells, and cell adhesion was
measured on collagen-I-coated plates 48–72 h after transfection.
When compared to cells that had been transfected with a small
interfering (si)RNA against luciferase, PR130-depleted cells indeed
showed increased adhesion (Fig. 6A). Morphometric analysis of
4G10-stained focal adhesions demonstrated a significant increase in
the number of focal adhesions per cell with an area >0.5 µm2
(measured 45 min after seeding) in PR130-depleted cells (Fig. 6B).
Overexpression of PR130 or the LPP-binding deficient PR130(60–
1150) mutant did not significantly affect cell–matrix adhesion
(Fig. 6C). Increased adhesion in PR130-depleted cells could be
rescued by reintroduction of a Myc-tagged RNAi-resistant form of
PR130 (Fig. 6A,D), but not by the LPP-binding deficient PR130
(60–1150) mutant (Fig. 6D), not only demonstrating specificity of
the siRNA, but also showing a requirement for LPP binding.
Immunoblotting confirmed the knockdown, as well as the
reconstitution, of PR130 and PR130(60–1150) (Fig. 6A,D).
PR130 is required for efficient cellmigration, through an LPP-
and PP2A/C-dependent mechanism
Our adhesion data inferred a role for the LPP–PR130-PP2A/C
complex in promoting dynamic focal contacts, which might also
play a role in cell migration. Previously, a positive role for LPP has
been reported in the migration of smooth muscle cells (Gorenne
et al., 2006), mouse embryonic fibroblasts (Vervenne et al., 2009)
and breast cancer cells (Ngan et al., 2013; Van Itallie et al., 2014).
Following transfection of HT1080 cells with siRNA against LPP or
siRNA against PR130, time-dependent knockdown was observed
for both LPP and PR130, without any compensatory changes in the
expression levels of their binding partners (PR130, LPP, PP2A/C
and the PP2A A subunit) (Fig. 7A). At 72 h post transfection, a
significant delay in wound closure was observed under conditions
where either LPP or PR130 was depleted, but not in the cultures that
had been transfected with buffer only (mock) or siRNA against
luciferase (luciferase siRNA) (Fig. 7B,C; Movies 1–3). Single-cell
tracking revealed that, upon knockdown of LPP or PR130, the
observed motility defects are attributable to decreased migration
speed, whereas the persistence of movement did not significantly
differ from that of the luciferase siRNA control (Fig. 7D). The LPP-
knockdown migration phenotype was found to be significantly
stronger than the PR130-knockdown phenotype (Fig. 7C), possibly
because the LPP knockdown was consistently more efficient than
the PR130 knockdown, and LPP-depleted cells showed difficulties
in reaching complete confluence at 72 h post transfection. The latter
is consistent with the previously reported role for LPP in E-
cadherin-dependent cell–cell adhesion (Hansen and Beckerle,
Fig. 3. LPP associates with a catalytically competent PR130-
PP2A holoenzyme. (A) Co-immunoprecipitation of endogenous
LPP, PR130, the PP2A A subunit PR65 (A/PR65) and C subunit
(PP2A C) from NIH3T3 cell lysates. LPP was immunoprecipitated
(IP) with anti-LPP antibodies and the presence of PR130, the
PP2AA subunit PR65 and PP2A/C in the immunoprecipitates was
evaluated by immunoblotting (IB). Ig, immunoglobulins; AB,
antibody. (B) PP2A activity assay on GFP-trapped complexes
from HEK293T cells expressing EGFP-tagged LPP or EGFP
alone. The pmole number of phosphate released from the
phosphopeptide (RRApTVA) was determined by using malachite
green. Okadaic acid (10−8M; OA) was added as a specificity
control. A representative assay is shown.
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2006; Van Itallie et al., 2014). To circumvent the need for a
confluent cell monolayer and, additionally, to exclude potential
matrix denudation influences in the wound healing assay, we
repeated the migration assays in Boyden chambers, which
recapitulate single-cell migration, rather than two-dimensional
sheet migration, and do not involve any potential denudation of
extracellular matrix. Similar results were found – both LPP- and
PR130-depleted cells showed decreased migration (Fig. 7E).
Notably, in some experiments, the LPP-knockdown cells (but not
the PR130-knockdown cells) showed signs of decreased viability,
Fig. 4. Cellular distribution of the endogenous
LPP–PR130 complex in fibrosarcoma cells. (A) In
adhering HT1080 cells. Cells were fixed and stained
1 h after seeding. The localisation of PR130 (Alexa-
Fluor-488), LPP (Cy3) and vinculin (Cy5) was
visualised by performing direct immunofluorescence
analysis. Scale bars: 10 µm. (B) The same
experiment as described in A in spread HT1080 cells.
Scale bars: 10 µm. Note the absence of PR130 in
elongated mature focal adhesions where vinculin and
LPP are clearly present (arrows). (C,D) In spread
HT1080 cells. The localisation of PR130 (Alexa-
Fluor-488) and LPP (Cy3) was visualised by
performing direct immunofluorescence analysis.
Arrows indicate focal adhesions (C). Open
arrowheads indicate cell–cell contacts (D). Scale
bars: 10 µm. (E) Immunoblots of LPP and PR130 in
protein lysates of trypsinised (‘in suspension’),
adhering (1 h after plating) and adherent and/or
spread (8 h after plating, adherent/spread) HT1080
cells. (F) Colocalisation of PR130 and paxillin in
spread and adhering HT1080 cells. The localisation
of PR130 (Alexa-Fluor-488) and paxillin (Alexa-Fluor-
594) was visualised by performing direct
immunofluorescence 6 h (spread) and 1 h (adhering)
after plating. White scale bars: 20 µm; yellow scale
bars: 14 µm. (G) Colocalisation of PR130 and
phospho-tyrosine in spread and adhering HT1080
cells. The localisation of PR130 (Alexa-Fluor-488)
and phospho-tyrosine residues (P-tyrosine 4G10,
Alexa-Fluor-594) was visualised by performing direct
immunofluorescence 6 h (spread) and 1 h (adhering)
after plating. White scale bars: 20 µm; yellow scale
bars: 14 µm.
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compromising an unambiguous interpretation of the LPP-depleted
cell phenotype. However, in light of previous results (Gorenne et al.,
2006; Vervenne et al., 2009; Ngan et al., 2013; Van Itallie et al.,
2014), at least part of the LPP-knockdown phenotype could be
ascribed to a cell migration defect. Thus, we confirmed the positive
involvement of LPP in cell migration and revealed the same now for
PR130.
The fact that knockdown of either protein in the LPP–PR130
complex gives rise to similar phenotypes is consistent with a
functional role for this complex in cell migration. To further confirm
this notion, we performed rescue experiments with RNAi-resistant
wild-type and mutant PR130 forms, which were Myc-tagged at the
C-terminus and used to generate stable polyclonal cell lines. In the
wound healing assay (Fig. 7F–H), two different mutants were used –
PR130 EFmut, predicted to lack the ability to bind Ca2+ and to bind
less PP2A/C (Janssens et al., 2003); and PR130(60–1150), which
lacks the LPP-binding domain (Fig. 2). In the Boyden chamber
assay (Fig. 7I–K), PR130(1–664), predicted to lack the ability to
bind PP2A/C, and the LPP-binding deficient PR130(60–1150)
mutant were used. Immunoprecipitations of Myc from lysates of the
stable cell lines showed the binding behaviour of the PR130 variants
towards LPP and PP2A/C (Fig. 7F,I). In the wound healing assays,
we observed that wild-type PR130 and PR130 EFmut partially
rescued the migratory defect caused by PR130 knockdown, whereas
the non-LPP-binding PR130(60–1150) mutant could not (Fig. 7G).
In the Boyden chamber assays, neither PR130(1–664) nor PR130
(60–1150) rescued the migration defect, as opposed to expression
of wild-type PR130, which resulted in a near-complete rescue
(Fig. 7J). These data indicate the specificity of the siRNA effects on
PR130 and further show a requirement for an interaction between
LPP and PP2A/C in the functional role of PR130 in cell migration.
Western blotting confirmed the knockdown and RNAi-resistance of
the rescue plasmids (Fig. 7H,K).
DISCUSSION
One of the major questions regarding Ser/Thr phosphatase
regulation is how target specificity is achieved. For PP2A, local
recruitment or targeting to defined locales is largely determined by
the regulatory B-type subunits (Slupe et al., 2011). The study here
provides a basis on which to understand a positive role for a specific
PP2A complex in cell migration and a negative role in cell–
substratum adhesion. This complex contains PR130/B″α1 as the
‘third’ distinguishing regulatory subunit, a specific splice variant
with a long 664-amino-acid N-terminal domain of unknown
function. We have used this domain as a bait to screen for
interacting partners and have identified the LIM protein LPP as an
interesting candidate. In parallel, LPP was identified, by performing
mass spectroscopy, as a specific co-immunoprecipitating protein in
PR130 immunocomplexes. Reciprocal immunoprecipitations
confirmed the presence of an endogenous PR130–LPP complex,
in which both the PP2A A and C subunits were also present. The
isolated LPP-associated PP2A complexes proved catalytically
active. PR130 specifically interacted with the LIM domains of
LPP – at least two (LIM2 and LIM3), and probably all three, LIM
Fig. 5. Exclusion of PR130 from focal adhesions is a function of PP2A activity. (A) Colocalisation of GFP–LPP–PR130 fusion proteins and phospho-tyrosine
in spread HT1080 cells. GFP–LPP (positive control), GFP–PR130(60–1150)–LPP and GFP–PR130(60–664)–LPP fusion proteins were expressed in HT1080
cells. At 48 h post transfection, cells were stained with the 4G10 clone anti-phospho-tyrosine monoclonal antibody (P-Tyrosine 4G10, Alexa-Fluor-594) to
visualise the focal adhesions (arrowheads). Scale bars: 20 µm. (B) Binding of GFP–LPP–PR130 fusion proteins to PP2A/C. GFP–PR130(60–1150)–LPP, GFP–
PR130(60–664)–LPP or GFP alone were isolated on GFP-trapping beads, and the presence of PP2A/C (PP2A C) in the trapped complexes was evaluated by
immunoblotting (IB). Expression and trapping of the fusion proteins was verified by anti-LPP immunoblotting. aa, amino acids.
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domains of LPP are required for the interaction, possibly because
they fold into a ‘superstructure’, as previously suggested (Petit et al.,
2003). Although LIM domains are postulated to be protein
interaction interfaces (Dawid et al., 1998; Bach, 2000), no
discrete consensus binding sequence or structural element has
emerged in their binding partners (Kadrmas and Beckerle, 2004).
Here, we show that PR130 interacts with the LPP LIM domains
through a well-conserved cysteine-rich, Zn2+-finger-like domain,
Fig. 6. PR130 inhibits HT1080 cell adhesion on collagen I in an LPP-dependent manner. (A) Representative immunoblot (IB) of total lysates of HT1080
cells used in adhesion assays, 72 h after transfection with siRNA against PR130 (RNAi PR130), with or without co-expression of RNAi-resistant Myc-tagged
PR130 (rescue). The average of triplicate measurements is shown for each condition tested in the adhesion assays, calculated relative to that of the sample
transfected with an siRNA against luciferase (RNAi LUC). Significancewas determined with Student’s t-test (***P=0.0005). Adhesion assays were repeated three
times, and the observed increase in adhesion in PR130-depleted cells was always in proportion with the degree of PR130 knockdown (which slightly differed
between experiments). (B) Focal adhesion (FA) morphometry in PR130-depleted cells. HT1080 cells that had been transfected with siRNA against luciferase or
PR130 (72 h post-transfection) were plated on collagen-I-coated cover slips, fixed 45 min later and stained with the phospho-tyrosine-specific 4G10 antibody.
Morphometric analysis was performed on individual cells (n=13–15) using ImageJ. Only focal adhesions with an area above 0.5 µm2 were taken into account
for analysis. Representative images of staining with the 4G10 antibody in both conditions are shown. Scale bars: 20 µm. (C) Same adhesion experiment as shown
in panel A, but in HT1080 cells ectopically expressing empty vector (pcDNA4), Myc–PR130 or Myc–PR130(60–1150). Three independent assays were
performed, with triplicate measurements for each condition in each assay. exp, exposure. (D) The same adhesion experiment as in panel C, but in HT1080 cells
that had been additionally depleted for endogenous PR130with siRNA. The dotted line indicates the represented lanes were originally not adjacent. Data are from
a single representative assay, with averages of triplicate measurements displayed for each condition, calculated relative to results of the RNAi LUC condition.
Significance was determined with Student’s t-test (**P<0.005). Data are mean±s.d. si, siRNA against the indicated protein.
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implying that the PR130–LPP interaction occurs through a Zn2+-
finger–Zn2+-finger interface. Despite the high degree of similarity
within the LIM domains of LPP and zyxin (Petit et al., 1996),
PR130 did not interact with zyxin in our binding assays. Such
selectivity has been demonstrated before for other LPP interacting
proteins, including Scrib (Petit et al., 2005a) and shelterin
(Sheppard et al., 2011). Thus, we have newly identified PR130 as
a cellular ligand for the LPP LIM domains and LPP as an adaptor for
a specific catalytically active PP2A complex, harbouring PR130 as
the regulatory B-type subunit.
An intriguing observation deriving from our localisation studies
of endogenous LPP and PR130 is that the two proteins colocalise in
Fig. 7. See next page for legend.
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dynamic focal contacts but that there is a striking absence of PR130
from mature (non-dynamic) focal adhesions, where LPP clearly
accumulates (Petit et al., 2003). It is well established that all three
LPP LIM domains cooperate to provide consistent targeting to focal
adhesions (Petit et al., 2003). Because PR130 interacts with these
LIM domains, focal adhesion targeting of LPP should therefore
co-occur with loss of PR130 binding, implying that LPP–PR130
complex formation is not constitutive but dynamic. Loss of PR130
from the focal-adhesion-associated LPP complex might perhaps
occur through competition with other LIM-domain-interacting
proteins that do colocalise with LPP in focal adhesions, such as,
for example, palladin (Jin et al., 2007) or supervillin (Takizawa
et al., 2006). An alternative disassembly mechanism might involve
selective proteolysis of PR130 by calpains, which are known to
regulate focal adhesion dynamics in cancer cells (Storr et al., 2011).
PR130 is indeed subject to limited proteolysis of its entire specific
N-terminal domain and part of its common C-terminal domain by
these proteases (Janssens et al., 2009). Regardless of the precise
dissociation mechanism, our localisation data also imply that the
sites of cell–substratum contact, where the LPP–PR130 complex
proteins colocalised, might be particularly dynamic in nature
because of the presence of PR130-PP2A. Such a hypothesis is well
supported by the failure of focal adhesion localisation of the GFP–
PR130(60–1150)–LPP fusion protein, whereas deletion of the
PP2A/C-binding domain reconstituted targeting of the fusion
protein to focal adhesions. Our functional cell adhesion and
migration assays provide additional support for this view. Loss of
PR130 expression indeed increased HT1080 cell adhesion onto
collagen I, whereas it inhibited cell migration in wound healing and
Transwell assays. Both PR130 functions require a functional
interaction with LPP because a non-LPP-binding PR130 mutant
failed to rescue the increase in cell adhesion and the decrease in cell
migration of PR130-depleted cells. The pro-migratory role of PR130
also requires a functional interaction with PP2A/C because a non-
PP2A/C-binding PR130mutant did not rescue themigration defect in
cells with suppressed PR130 expression in a Transwell assay.
Although in the wound healing assay potential matrix denudation
might specifically have influenced the PR130-depleted cells, this
possibility was excluded in the Transwell assay, favouring the
conclusion that the LPP–PR130-PP2A interaction contributes to the
dynamic nature of cell–substratum contacts in moving cells.
Although the requirement for LPP and PP2A/C binding can be
well documented, it is less clear whether Ca2+ binding is also
important for the function of PR130 in cell migration. Both re-
expression of wild-type PR130 or PR130 EFmut could indeed rescue
the migration defect of PR130-depleted cells, suggesting that Ca2+-
binding or potential Ca2+-induced changes in PR130-PP2A
phosphatase activity is not very important in the pro-migratory role
of PR130.Although the PR72EFmut construct interacts substantially
less with PP2A/C as compared to wild-type PR72 (Janssens et al.,
2003;Ahn et al., 2007), the interaction of PR130EFmutwith PP2A/C
was diminished to a much lesser extent as compared to wild-type
PR130 (Fig. 7F), indicative of additional contributing interaction
interfaces in PR130, such as the reported hydrophobic motif (Davis
et al., 2008; Wlodarchak et al., 2013). Hence, the ability of PR130
EFmut to rescue knockdown remains consistent with a functional
role for the phosphatase complex in these events.
In line with our observations describing a positive role for PR130
in cell migration, it has been reported that PR130 is involved in
planar cell polarity signalling in Xenopus embryogenesis
(Creyghton et al., 2006). More recently, a similar role has been
Fig. 7. PR130 promotes efficient HT1080 cell migration in an LPP-
dependent manner. (A) RNAi-mediated knockdown of PR130 and LPP.
HT1080 cells were transfected with buffer (mock) or an siRNA duplex (10 nM)
directed against PR130, LPP or luciferase (siPR130, siluci and siLPP,
respectively). Extracts were prepared in SDS-sample buffer at the indicated
times post transfection and subjected to immunoblotting. The same blot was
developed, stripped and re-probed with the indicated antibodies. (B) Wound
healing assays. A wound was made in a confluent cell layer of HT1080 cells
72 h post transfection with the indicated siRNA duplexes (mock=buffer).
Wound closure was followed as a function of time by taking a picture every 10
min. After 9 h, the wounds of the control cells (mock and RNAi luciferase) had
virtually closed, whereas this was not the case in cells with suppressed PR130
or LPP expression. These images are of a representative experiment.
Time-lapse videos of the migrating cells can be found in Movies 1–3.
(C) Quantification of migration speed in the different conditions. The reduction
of wound area was measured as a function of time using MetaMorph software.
All data were related to the mock-transfected cells (control), for which the
migration speed was set to 100%. The results represent themean±s.d. of three
independent experiments. A Student’s t-test was applied to assess statistical
significance of the observed differences with the control (mock) condition
(P=0.022 for siPR130; P=0.007 for siLPP; *P<0.05). There is also a statistical
difference between siPR130 and siLPP (P=0.011). (D) Individual cell tracking.
This analysis was performed with the tracking software for the indicated
number of cells transfected with siRNAs against the indicated proteins
(luciferase, control). Statistical analysis of the tracks was performed with
Mathematica software, and is represented in the two right-most box and
whisker diagrams (the box represents the first and third quartile of the
measured values of the given parameter, the line represents the median of the
measured values of the given parameter and the whiskers represent the
minimal and the maximal measured values of the given parameter).
(E) Transwell migration assays. Single-cell migration through an 8.0-µm-pore
membrane along a gradient of 0–10% FCS was determined at 72 h post-
transfection of HT1080 cells with siRNAs against luciferase (luci), LPP and
PR130. Migrated cells were labelled with Calcein-AM and quantified by
measuring fluorescence. Results represent the mean of two independent
experiments, in which each condition was measured in triplicate. Asterisks
indicate a statistically significant differencewith cells transfected with an siRNA
against luciferase (*P<0.05). (F–H) Rescue of the migration defect in the
wound healing assays by wild-type PR130 and PR130 EFmut, but not by the
non-LPP-binding PR130(60–1150) mutant. Polyclonal HT1080 cells stably
expressing a putative rescue plasmid encoding C-terminally Myc-tagged
RNAi-resistant PR130, PR130 EFmut or PR130(60–1150), or Myc alone were
selected with zeocin. (F) Anti-Myc immunoprecipitations (IP) confirmed the
expression of the rescue proteins (anti-PR130 blot), and their binding
behaviour to endogenous LPP and PP2A/C. (G) At 72 h after transfection with
the siRNA duplex against PR130 or luciferase, the stable cell lines were
subjected to a wound healing assay. (H) 12 h later, when the wound of the
control condition was completely closed, extracts were prepared in SDS
sample buffer to evaluate knockdown of endogenous PR130 and RNAi-
resistance of the rescue proteins. The wound healing data are expressed as
the mean±range of two independent experiments in which each condition was
performed in duplicate. Asterisks indicate a statistically significant difference
with the control (vector-transfected HT1080 cells treated with siPR130) – for
wild-type PR130 rescue, P=0.034; for PR130 EFmut rescue, P=0.016. The
western blot (IB) in panel H shows a single representative experiment. (I–K)
Rescue of themigration defect in the Transwell assays by wild-type PR130, but
not by the non-PP2A/C-binding PR130(1–664) mutant or the non-LPP-binding
PR130(60–1150) mutant. (I) Polyclonal HT1080 cells stably expressing a
putative rescue plasmid encoding C-terminally Myc-tagged RNAi-resistant
PR130, PR130(60–1150), PR130(1–664) or Myc alone were selected with
zeocin. Anti-Myc immunoprecipitations (IPs) confirmed expression of the
rescue proteins (anti-Myc blot) and their binding behaviour to endogenous LPP
and PP2A/C. (J) At 72 h after transfection with the siRNA duplexes against
PR130 or luciferase, the stable cell lines were subjected to a Transwell
migration assay. (K) A small aliquot of each cell suspension was kept to
prepare protein extracts and to evaluate the knockdown of endogenous PR130
and RNAi-resistance of the rescue proteins (IB with PR130- and Myc-specific
antibodies). Each condition was performed in triplicate, and means±s.d. are
displayed of a single representative experiment. Asterisks indicate a
statistically significant difference with the control condition (si-luci-treated
cells). *P<0.05; **P<0.005 (Student’s t-test).
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demonstrated for LPP in the regulation of convergence-extension
movement in zebrafish (Vervenne et al., 2008). Consistently, LPP−/−
mouse embryonic fibroblasts exhibit reduced migration capacity in a
wound healing assay (Vervenne et al., 2009), and depletion of LPP
reduces the migration of smooth muscle cells (Gorenne et al., 2006)
and breast cancer cells (Ngan et al., 2013; Van Itallie et al., 2014).
These reports thus confirm a positive role for PR130 and LPP in cell
motility. We speculate that a major function of LPP in determining
this cell behaviour is to act as a scaffold that brings a specific PP2A
heterotrimer into close contact with potential substrates, the dynamic
(de)phosphorylation of which might efficiently steer cell migration
or prevent focal adhesion maturation. Such candidate substrates
might be Scrib, vasodilator-stimulated phosphoprotein (VASP),
LIM and SH3 protein 1 (LASP-1) or palladin – which are all
established LPP interaction partners (Petit et al., 2005b, 2000;
Keicher et al., 2004; Jin et al., 2007), phosphoproteins on Ser/Thr
residues (Yoshihara et al., 2011;Metodieva et al., 2013; Döppler and
Storz, 2013; Butt et al., 2003; Keicher et al., 2004; Asano et al.,
2011) and known actin cytoskeleton modulators regulating cell
adhesion, migration or polarity (Qin et al., 2005; Döppler and Storz,
2013; Orth et al., 2015; Najm and El-Sibai, 2014). Future research
efforts should further clarify whether PR130-PP2A does indeed
regulate dephosphorylation of these proteins and how this relates to
the pro-migratory role of the LPP–PR130-PP2A complex discovered
here. Earlier work has already demonstrated a role for a specific
PP2A-B′γ1 complex in regulating paxillin dephosphorylation at
focal adhesions (Ito et al., 2000) – further underscoring the
importance of localised regulation of protein dephosphorylation at
sites of cell–substratum contacts – as well as the major determining
role of specific PP2A regulatory B-type subunits in these processes.
The demonstration of a direct, specific and strong interaction
between PR130 and LPP might suggest yet other cellular functions
of this complex, besides the ones demonstrated here. LPP is indeed
also involved in the regulation of (epithelial) cell–cell contacts
(Hansen and Beckerle, 2006; Van Itallie et al., 2014) and has been
described as a transcriptional co-activator (Guo et al., 2006) and
telomere-binding protein (Sheppard and Loayza, 2010) in the
nucleus. Given the apparent colocalisation of PR130 and LPP at
these specific subcellular locales, it is tempting to speculate that
PP2A-PR130 also regulates LPP function in these particular
processes.
Although we have identified a role for the LPP–PR130 complex
in adhesion andmigration control in HT1080 fibrosarcoma cells, the
presence of the complex in several independent cell lines, both
normal and transformed, suggests a general mechanism. Alongside
earlier work highlighting a positive role for PR130 in canonicalWnt
signalling (Creyghton et al., 2006) and EGF-dependent signalling
(Zwaenepoel et al., 2010), our current findings highlight a positive
role for PR130 in (cancer) cell migration and a negative role in
(cancer) cell–substratum adhesion through the dynamic interaction
with LPP. Thus, alongside its tumour suppressor properties in one
complex (Westermarck and Hahn, 2008), PP2A might also be
involved in growth stimulation, tumour progression and metastasis
in another. Specifically, the latter complexes could constitute
interesting therapeutic targets for pharmacological intervention.
MATERIALS AND METHODS
Generation of plasmids and site-directed mutagenesis
Classic molecular biology techniques were used to subclone PR130, LPP or
fragments thereof, into different plasmids. Restriction enzymes, Antarctic
phosphatase and T4 DNA ligase were from New England Biolabs. GFP-
PR130(60–1150)–LPP and GFP–PR130(60–664)–LPP fusion proteins
were generated into pEGFP-C1 using In-Fusion® technology (Clontech).
EGFP-tagged zyxin, LPP LIM domains and LIM-domain point mutants
have been described previously (Petit et al., 2003). GST fusions were
expressed from pGMEX-T3 (Amersham), EGFP-tagged proteins from
pEGFP-C1 or pEGFP-N1 (Clontech), Myc-tagged proteins from pcDNA4
Tet-on (Invitrogen). The Myc-tag was included in one of the
oligonucleotides used to generate the appropriate PCR products. All PCR
reactions were performed with proofreading PwoDNA polymerase (Roche)
and oligonucleotides from Sigma-Genosys. For site-directed mutagenesis,
the QuickChange protocol (Stratagene) was used. All inserts of the
recombinant plasmids were verified by sequencing.
Antibodies
We used the following commercial antibodies: goat anti-LPP (clone N-20,
catalogue number sc-27312) and rabbit anti-GST (clone Z-5, catalogue
number sc-459) antibodies (Santa Cruz Biotechnologies); mouse anti-α-
tubulin (cloneB-5-1-2, cataloguenumberT5168), anti-vinculin (clone hVIN-1,
catalogue number V9264) and anti-FLAG (clone M2, catalogue number
F1804) antibodies (Sigma); anti-phospho-tyrosine (clone 4G10, catalogue
number 05-321) and anti-paxillin (clone 5H11, catalogue number 05-417)
antibodies (Millipore). Mouse anti-Myc (clone 9E10) and anti-EGFP (clone
GFP4E12/8) antibodies were from Cancer Research UK monoclonal
antibody services; monoclonal anti-PP2A/C (clone F2.6AID) and anti-
PP2A subunit A (clone C5.3D10) antibodies were a generous gift from
Dr S. Dilworth (University of Middlesex, London, UK). Rabbit anti-PR130
and anti-LPP antibodies were as described previously (Zwaenepoel et al.,
2008; Petit et al., 2000). For immunoblotting, dilutions were 1/1000; for
immunofluorescence 1/50. Horseradish peroxidase (HRP)-conjugated
secondary antibodies for western blotting were donkey anti-rabbit and
sheep anti-mouse (Amersham), and swine anti-goat (Dako). Secondary
antibodies used for immunofluorescence (dilutions: 1/800) were: Alexa-
Fluor-488-conjugated donkey anti-rabbit or anti-mouse, and Alexa-Fluor-
594-conjugated donkey anti-mouse antibodies (Molecular Probes), and
Cy3-conjugated donkey anti-goat and Cy5-conjugated donkey anti-mouse
antibodies (Jackson).
Yeast two-hybrid screening
The cDNA encoding PR130(1–664) was PCR amplified and cloned into
SmaI-digested pGBKT7. This plasmid was the bait to screen 2.5×106 clones
of a Matchmaker testis pACT library in the AH109 S. cerevisiae strain using
standard procedures (Clontech). The initial screening was performed on X-
α-Gal-containing medium lacking adenine and histidine. The protocols used
are as in the ‘Matchmaker GAL4 Two-Hybrid System 3 user manual’ and
‘Yeast protocol handbook’ at www.clontech.com/clontech/techinfo/
manuals. After a second screening round to eliminate false positives, the
remaining library plasmids were isolated and the inserts sequenced.
Protein fingerprinting and mass spectroscopy
For identification of PR130 co-immunoprecipitating proteins, lysates of
5×15-cm dishes of confluent NIH3T3 cells were used per condition. Anti-
PR130 immunocomplexes were resolved on 4–12% NuPage gels
(Invitrogen) and stained with Coomassie Brilliant Blue. Bands of interest
were excised, trypsinised and the peptide mixtures analysed on a MALDI-
TOF instrument (Micromass). The proteins giving rise to the resulting
peptide sequences were identified by using a Mascott MS/MS ion search.
Three tryptic peptides of murine LPP were retrieved from the 75-kDa
protein band present in anti-PR130 immunoprecipitates: residues 297–311,
YYEPYYAAGPSYGGR; residues 330–353, EAAYAPPASGNQNHPG-
MYPVSGPK; residues 401–416, MLYDMENPPADDYFGR.
RNA interference
All siRNA duplexes were purchased from Qiagen: PR130 sense r(ACCA-
UGCAGCUUACAGAAAUU), PR130 antisense r(UUUCUGUAAGCU-
GCAUGGUUU), LPP sense r(GUCCCAAGAAGACCUAUAU)dTdT,
LPP antisense r(AUAUAGGUCUUCUUGGGAC)dCdA, luciferase sen-
se r(UACGCGGAAUACUUCGAUU)dTdT, luciferase antisense r(AA-
UCGAAGUAUUCCGCGUA)dCdG (‘r’ denotes ‘RNA’ and ‘d’ denotes
‘DNA’ nucleotides). They were transfected into HT1080 cells (100,000
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cells/well in a 24-well plate) at a final concentration of 10 nM with 3–4 µl
of Hiperfect reagent (Qiagen). To make RNAi-resistant PR130, three
point mutations were introduced into the PR130 target sequence
(ACCATGCAGCTTACAGAAA was mutated into ACCATGCAGCAT
ATCGAAA).
Immunoprecipitations, GST pull downs and GFP-trapping
Total cell extracts were prepared in NET buffer (50 mM Tris-HCl pH 7.4,
150 mM NaCl, 15 mM EDTA, 1% NP-40) supplemented with complete
protease and phosphatase inhibitor cocktail (Roche). For
immunoprecipitations, the lysates were incubated for 2–3 h with the
appropriate antibodies on a rotating wheel at 4°C. Protein G Sepharose
beads (Sigma) were added for 15 min, and the beads were washed twice in
NET buffer, twice in TBS+0.1% NP-40 and once in TBS. For GST pull
downs, the lysates were incubated with glutathione–Sepharose (Amersham) in
NENT100 buffer (20 mMTris-HCl pH 7.4, 1 mM EDTA, 0.1%NP-40, 25%
glycerol, 100 mM NaCl), supplemented with 2 mg/ml BSA on a rotating
wheel for 1 h at 4°C. The beads were washed twice in NENT300 (NENT100
with 300 mMNaCl instead of 100 mM) plus 2 mg/ml BSA, and three times in
NENT300 without BSA. For GFP-trapping, cell lysates were incubated at 4°C
for 1 h with wash buffer (10 mM Tris-HCl pH 7.5, 0.5 mM EDTA and
150 mM NaCl) and 15 µl of GFP-trap-A beads (Chromotek). Beads were
washed four times inwash buffer. Inmost cases, bound proteinswere eluted in
2× SDS sample buffer at 98°C and further analysed by immunoblotting.
Measurement of PP2A activity
GFP-trapped complexes were washed with 20 mM Tris-HCl pH 7.4+1 mM
DTT and resuspended in 80 µl of enzyme dilution buffer (Millipore,
catalogue number 20-169). One half (40 µl) was pre-incubated (10 min on
ice) with okadaic acid (Calbiochem) at a final concentration of 10−8 M; the
other half was left untreated. The phosphatase assay was performed on
300 µM of RRApTVA phospho-peptide (lowercase p denoting
phosphorylation of the following threonine residue) for different time
points at 30°C, all in the linear range of the assay. The released free phosphate
was determined by addition of malachite-green solution, composed of a 10:1
mix of solutions A and B (Millipore, catalogue numbers 20-105 and 20-104,
respectively). Absorbance at 630 nm was measured in a multi-channel
spectrophotometer. The pmole number of released phosphate was calculated
by comparison with a standard curve of KH2PO4.
Cell-based assays
HT1080, COS7 andNIH3T3 cells (all fromAmericanTypeCulture Collection
and used at early passage number after being revived) were grown in DMEM
+10% foetal calf serum (Sigma) or 10%donor calf serum (Sigma) for NIH3T3
cells. Plasmid transfections were performed with Fugene6 Reagent (Roche) in
Optimem (Life Technologies) according to the manufacturer’s instructions.
For selection of stable cell lines, HT1080 cells were split 1 in 4 into growth
medium containing 400 µg/ml zeocin (Invitrogen) 36 h after transfection with
the pcDNA4T/O-derived plasmids. Resistant clones were pooled and frozen,
and the early passages were used for rescue experiments.
For immunofluorescence analysis, cells were grown on acid-washed
collagen-I-coated coverslips in 24-well plates. Cells were washed twice in
PBS supplemented with 1 mM CaCl2 and 0.5 mM MgCl2 and fixed in 4%
paraformaldehyde (PBS) for 15 min at room temperature. Free aldehydes
were quenched in 50 mM NH4Cl for 10 min. Cells were permeabilised in
0.2%Triton X-100 (PBS) for 15 min and blocked in 1.5%BSA (PBS) for 30
min. Incubation with primary antibodies was performed for 45 min at room
temperature. After three washes in PBS, incubation with the secondary
antibodies was for 30–45 min. After three washes in PBS and one wash in
water, the cells were mounted in DAPI-containing mounting medium
(Molecular Probes). All images were captured on a confocal laser scanning
microscope (LSM510, Carl Zeiss) equipped with a 63×/1.4 Plan-
Apochromat oil immersion objective.
For adhesion assays, 20,000 HT1080 cells/well were plated onto 24-well
plates that had been coated with collagen I (1 mg/ml) (Sigma). Each
condition was performed in triplicate. After 20 min of adhesion, non-
adhering cells were gently washed off, and adhering cells were incubated for
an additional hour at 37°C. Next, cells were washed with PBS, fixed with
4% paraformaldehyde and coloured with 0.5%Crystal Violet (Sigma). After
three washing steps in water, cells were lysed in 0.5% Triton X-100, and the
released Crystal Violet measured at 595 nm in a spectrophotometer.
Morphometric analysis of focal adhesions was executed in cells 45 min after
plating on collagen-I-coated cover slips. Focal adhesions were stained using
an antibody recognising phospho-tyrosine residues (clone 4G10). Images of
several random fields were acquired on a Leica LSM510 inverted confocal
microscope using a ×63 1.2 Plan-Apochromat oil objective (Leica) with a
pinhole of 0.8 to minimise the z-section. Then, 8-bit images were captured
and pixel size was 0.1395×0.1395 µm2. Processing and analysis of the focal
adhesions of individual cells (n=13–15) was executed with ImageJ using the
tools ‘Background subtraction’, ‘adjustment of brightness and contrast’,
‘edge finding’, ‘adjustment of threshold’ and ‘particle analysis’ with
size=0.5 and circularity=0–1 as set parameters. Using these settings, only
focal adhesions >0.5 µm2 were included in the final analysis.
To monitor migration, a wound was made in a confluent layer of HT1080
cells seeded on a 24-well plate. The cells were washed with medium to
remove all non-adherent cells, and the wound was allowed to close in
complete medium supplied with 20 mM Hepes pH 7.4 at 37°C. Wound
healing was followed on a light microscope (Carl Zeiss) equipped with a
moveable stage, a 10× objective and an Orca ER CCD camera
(Hamamatsu). Every 10 min, a picture was taken, and the resulting data
were analysed with MetaMorph software. Cell tracking was performed with
Tracking software and analysed with Mathematica software. Single-cell
migration was monitored in Boyden chambers (ThinCert™ Transwell
inserts for 24-well plates, 8.0 µm pore, Greiner Bio-one), largely according
to the accompanying ‘Application Note’ protocol for HT1080 cells (www.
gbo.com/bioscience). In short, 100,000 cells were seeded in serum-free
medium+0.2% BSA (Sigma), and the lower reservoir additionally contained
10% FCS. After incubation at 37°C for 12 h, the inserts were incubated for
45 min at 37°C in serum-free medium containing 0.2% BSA and 8 µM
Calcein-AM (Sigma). Cells at the outside bottom of the inserts were
trypsinised for 10 min (37°C) in a new well containing 450 µl trypsin
(0.05%) with EDTA (0.02%) (Sigma). 200 µl of cell suspension was
transferred to a black F-bottom 96-well plate (Greiner Bio-one) and
fluorescence (excitation: 485 nm; emission: 520 nm) was determined on a
Flex Station 3 instrument (Molecular Probes).
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Creyghton, M. P., Roël, G., Eichhorn, P. J. A., Hijmans, E. M., Maurer, I., Destrée,
O. and Bernards, R. (2005). PR72, a novel regulator of Wnt signaling required for
Naked cuticle function. Genes Dev. 19, 376-386.
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